Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.31 |
| ▸ | PTPN5 | P54829 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1069850 | 0.86 | — | — | |
| SCHEMBL1777259 | 0.82 | LMNA (0.33) | LMNATRPA1PTGS1CACNA1CALDH1A1 | |
| SCHEMBL457652 | 0.72 | KIF11 (0.32) | — | |
| SCHEMBL1031444 | 0.72 | LMNA (0.35) | LMNATRPA1PTGS1CACNA1CALDH1A1 | |
| SCHEMBL10180211 | 0.72 | PDK2 (0.30) | PDK2 | |
| SCHEMBL3284666 | 0.72 | PDK2 (0.37) | PDK2PTPN5ALDH1A1GAAALOX12 | |
| SCHEMBL15067062 | 0.72 | LMNA (0.38) | LMNATRPA1PTGS1CACNA1CALDH1A1 | |
| SCHEMBL677008 | 0.70 | LMNA (0.37) | LMNATRPA1PTGS1CACNA1CALDH1A1 | |
| SCHEMBL2444018 | 0.70 | LMNA (0.41) | LMNATRPA1PTGS1CACNA1CALDH1A1 | |
| SCHEMBL149760 | 0.70 | TSHR (0.37) | PTPN5ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070185059-A1 | Antiallergic agents | INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) | 2007-08-09 | — | — | US | claimed |
| EP-2423188-B1 | Intermediates in the preparation of agricultural/horticultural insecticides and method for using the same | MITSUI CHEMICALS AGRO INC (JP) | 2021-03-10 | — | — | EP | disclosed |
| EP-1661886-B1 | INSECTICIDE FOR AGRICULTURAL OR HORTICULTURAL USE AND METHOD OF USE THEREOF | MITSUI CHEMICALS AGRO INC (JP) | 2016-08-10 | — | — | EP | disclosed |
| CN-102718665-B | Insecticide for agricultural or horticultural use prepare intermediate | MITSUI CHEMICAL INDUSTRY CO., LTD. (JP) | 2015-09-16 | — | — | CN | disclosed |
| CN-104892431-A | Insecticide for agricultural or horticultural use and method of use thereof | MITSUI CHEMICALS INC | 2015-09-09 | — | — | CN | disclosed |
| US-9101135-B2 | Agricultural/horticultural insecticide and method for using the same | MITSUI CHEMICALS, INC. (JP) | 2015-08-11 | — | — | US | disclosed |
| US-9089133-B2 | Insecticide for agricultural or horticultural use and method of use thereof | MITSUI CHEMICALS, INC. (JP) | 2015-07-28 | — | — | US | disclosed |
| CN-102976984-B | Preparation intermediate of insecticide for agricultural and horticultural uses | MITSUI CHEMICALS INC | 2015-04-08 | — | — | CN | disclosed |
| US-20140303377-A1 | AGRICULTURAL/HORTICULTURAL INSECTICIDE AND METHOD FOR USING THE SAME | MITSUI CHEMICALS, INC. (JP) | 2014-10-09 | — | — | US | disclosed |
| US-8816128-B2 | Insecticide for agricultural or horticultural use and method of use thereof | MITSUI CHEMICALS, INC. (JP) | 2014-08-26 | — | — | US | disclosed |
| EP-1512396-A1 | INHIBITORS AGAINST THE ACTIVATION OF AP-1 AND NFAT | Institute of Medicinal Molecular Design, Inc. (JP) | 2005-03-09 | — | — | EP | disclosed |
| EP-1510210-A1 | IMMUNITY-RELATED PROTEIN KINASE INHIBITORS | Institute of Medicinal Molecular Design, Inc. (JP) | 2005-03-02 | — | — | EP | disclosed |
| EP-1510207-A1 | THERAPEUTIC DRUG FOR DIABETES | Institute of Medicinal Molecular Design, Inc. (JP) | 2005-03-02 | — | — | EP | disclosed |
| EP-1467997-A1 | PYRROLOPYRIMIDINE AND PYRROLOPYRIDINE DERIVATIVES SUBSTITUTED WITH CYCLIC AMINO GROUP | Taisho Pharmaceutical Co. Ltd. (JP) | 2004-10-20 | — | — | EP | disclosed |
| US-20040157851-A1 | CRF receptor antagonists and methods relating thereto | NEUROCRINE BIOSCIENCES, INC. | 2004-08-12 | — | — | US | disclosed |
| WO-2004058767-A1 | PYRROLOPYRIMIDINE AND PYRROLOPYRIDINE DERIVATIVES SUBSTITUTED WITH CYCLIC AMINO GROUP | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2004-07-15 | — | — | WO | disclosed |
| US-20040087589-A1 | CRF receptor antagonists and methods relating thereto | NEUROCRINE BIOSCIENCES, INC. | 2004-05-06 | — | — | US | disclosed |
| US-6531475-B1 | CRF receptor antagonists and methods relating thereto | NEUROCRINE BIOSCIENCES, INC. | 2003-03-11 | — | — | US | disclosed |
| US-6514982-B1 | Corticotropin releasing factor is believed to be the major physiological regulator of the basal and stress-release of adrenocorticotropic hormone, beta -endorphin, and other pro-opiomelanocortin-derived peptides from the pituitary | NEUROCRINE BIOSCIENCES, INC. | 2003-02-04 | — | — | US | disclosed |
| WO-2001087885-A1 | CRF RECEPTOR ANTAGONISTS | NEUROCRINE BIOSCIENCES, INC. (US) | 2001-11-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140303377-A1 | AGRICULTURAL/HORTICULTURAL INSECTICIDE AND METHOD FOR USING THE SAME | CBR3, ATL3, CNPY2 | PDK2 3756/4885LMNA 4134/4885TRPA1 1051/4885 |
| US-20040157851-A1 | CRF receptor antagonists and methods relating thereto | CRHR1, CRHR2, MC2R | PDK2 4476/4885LMNA 2102/4885TRPA1 729/4885 |
| US-20070185059-A1 | Antiallergic agents | NAT1, EPX, AHR | PDK2 2326/4885LMNA 1423/4885TRPA1 102/4885 |
| US-20040087589-A1 | CRF receptor antagonists and methods relating thereto | CRHR1, CRHR2, MC2R | PDK2 4476/4885LMNA 2102/4885TRPA1 729/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.